144 related articles for article (PubMed ID: 29148282)
1. Macrocarpal C isolated from Eucalyptus globulus inhibits dipeptidyl peptidase 4 in an aggregated form.
Kato E; Kawakami K; Kawabata J
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):106-109. PubMed ID: 29148282
[TBL] [Abstract][Full Text] [Related]
2. [Studies on chemical constituents in fruits of Eucalyptus globulus].
Yang XW; Guo QM
Zhongguo Zhong Yao Za Zhi; 2007 Mar; 32(6):496-500. PubMed ID: 17552153
[TBL] [Abstract][Full Text] [Related]
3. Semisynthesis of macrocarpal C and analogues by selective dehydration of macrocarpal A or B.
Alliot J; Gravel E; Larquetoux L; Nicolas M; Doris E
J Nat Prod; 2013 Dec; 76(12):2346-9. PubMed ID: 24261967
[TBL] [Abstract][Full Text] [Related]
4. Eucalyptone from Eucalyptus globulus.
Osawa K; Yasuda H; Morita H; Takeya K; Itokawa H
Phytochemistry; 1995 Sep; 40(1):183-4. PubMed ID: 7546549
[TBL] [Abstract][Full Text] [Related]
5. Euglobal-In-1, a new euglobal from Eucalyptus incrassata.
Takasaki M; Konoshima T; Kozuka M; Haruna M; Ito K; Crow WD; Paton DM
Chem Pharm Bull (Tokyo); 1994 Oct; 42(10):2113-6. PubMed ID: 7805137
[TBL] [Abstract][Full Text] [Related]
6. Macrocarpals H, I, and J from the Leaves of Eucalyptus globulus.
Osawa K; Yasuda H; Morita H; Takeya K; Itokawa H
J Nat Prod; 1996 Sep; 59(9):823-7. PubMed ID: 8864235
[TBL] [Abstract][Full Text] [Related]
7. Tyrosinase inhibitors from the leaves of Eucalyptus globulus.
Lin QM; Wang Y; Yu JH; Liu YL; Wu X; He XR; Zhou ZW
Fitoterapia; 2019 Nov; 139():104418. PubMed ID: 31704262
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
Patel BD; Bhadada SV; Ghate MD
Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
[TBL] [Abstract][Full Text] [Related]
9. Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
Li N; Wang LJ; Jiang B; Li XQ; Guo CL; Guo SJ; Shi DY
Eur J Med Chem; 2018 May; 151():145-157. PubMed ID: 29609120
[TBL] [Abstract][Full Text] [Related]
10. The discovery of novel 5,6,5- and 5,5,6-tricyclic pyrrolidines as potent and selective DPP-4 inhibitors.
Cox JM; Chu HD; Kuethe JT; Gao YD; Scapin G; Eiermann G; He H; Li X; Lyons KA; Metzger J; Petrov A; Wu JK; Xu S; Sinha-Roy R; Weber AE; Biftu T
Bioorg Med Chem Lett; 2016 Jun; 26(11):2622-6. PubMed ID: 27106708
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?
Juillerat-Jeanneret L
J Med Chem; 2014 Mar; 57(6):2197-212. PubMed ID: 24099035
[TBL] [Abstract][Full Text] [Related]
12. Features of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides from dietary proteins.
Nongonierma AB; FitzGerald RJ
J Food Biochem; 2019 Jan; 43(1):e12451. PubMed ID: 31353485
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and potent inhibitory activities of carboxybenzyl-substituted 8-(3-(R)-aminopiperidin-1-yl)-7-(2-chloro/cyanobenzyl)-3-methyl-3,7-dihydro-purine-2,6-diones as dipeptidyl peptidase IV (DPP-IV) inhibitors.
Mo DW; Dong S; Sun H; Chen JS; Pang JX; Xi BM; Chen WH
Bioorg Med Chem Lett; 2015 May; 25(9):1872-5. PubMed ID: 25838146
[TBL] [Abstract][Full Text] [Related]
14. Constituents of
Kim BR; Paudel SB; Nam JW; Jin CH; Lee IS; Han AR
Molecules; 2020 Sep; 25(19):. PubMed ID: 32977609
[TBL] [Abstract][Full Text] [Related]
15. Discovery of anthraquinones as DPP-IV inhibitors: Structure-activity relationships and inhibitory mechanism.
Ma HH; Zhang J; Li CQ; Zou LW
Fitoterapia; 2023 Jul; 168():105549. PubMed ID: 37244503
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Biological Evaluation, and QPLD Studies of Piperazine Derivatives as Potential DPP-IV Inhibitors.
Khalaf RA; Jarad HA; Al-Qirim T; Sabbah D
Med Chem; 2021; 17(9):937-944. PubMed ID: 32940185
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl peptidase IV Inhibitory activity of Terminalia arjuna attributes to its cardioprotective effects in experimental diabetes: In silico, in vitro and in vivo analyses.
Mohanty IR; Borde M; Kumar C S; Maheshwari U
Phytomedicine; 2019 Apr; 57():158-165. PubMed ID: 30668318
[TBL] [Abstract][Full Text] [Related]
18. Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation.
Meduru H; Wang YT; Tsai JJ; Chen YC
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304951
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (Part II): in silico prediction in antidiabetic extracts.
Guasch L; Sala E; Ojeda MJ; Valls C; Bladé C; Mulero M; Blay M; Ardévol A; Garcia-Vallvé S; Pujadas G
PLoS One; 2012; 7(9):e44972. PubMed ID: 23028712
[TBL] [Abstract][Full Text] [Related]
20. DPP-IV Inhibitory Potentials of Flavonol Glycosides Isolated from the Seeds of
Kim BR; Kim HY; Choi I; Kim JB; Jin CH; Han AR
Molecules; 2018 Aug; 23(8):. PubMed ID: 30103438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
